ReadCoor Honored by Goldman Sachs for Entrepreneurship – CEO, CTO, and Founder Richard Terry Among 100 Most Intriguing Entrepreneurs at 2020 Builders + Innovators Summit

October 14, 2020

CAMBRIDGE, Mass., October 14, 2020 – ReadCoor, a company leading true multi-omic spatial sequencing, today announced Goldman Sachs (NYSE:GS) is recognizing Chief Executive Officer (CEO), Chief Technology Officer (CTO) and Founder Richard Terry as one of the 100 Most Intriguing Entrepreneurs of 2020 at its Builders + Innovators Summit.

Goldman Sachs selected Terry as one of 100 entrepreneurs from multiple industries to be honored at the two-day event. He co-founded ReadCoor in 2016 with Harvard Medical School professor, Dr. George Church. Terry’s extensive experience in the translation and commercialization of high-impact technologies, and leadership of cross-functional teams enabled ReadCoor’s rapid acceleration to become the leader in True Multi-omic Spatial Sequencing Technology. He led the spin out of the company from the Wyss Institute for Biologically Inspired Engineering Harvard University where he oversaw the translation of this technology from initial inception through its startup launch. This year, ReadCoor launched its platform products and Select Release Program for use by researchers focusing on initial applications in immuno-oncology, neuroscience, and infectious disease. Earlier this month, the company was acquired by 10x Genomics for $350 million in cash and stock to join forces in pioneering groundbreaking In situ products.

“I founded ReadCoor to have a dramatic impact on medicine and healthcare by providing researchers products that offer unprecedented insights into human biology. I am tremendously excited Goldman Sachs has recognized our success,” said Richard Terry, CEO, CTO, and Founder of ReadCoor.

“True innovation is built from a diversity of perspectives and experiences”, said David M. Solomon, Chief Executive Officer of Goldman Sachs. “Our Builders + Innovators Summit brings together a collective of impressive future leaders who are striving to drive meaningful change. For over 150 years, Goldman Sachs has supported entrepreneurs as they launch and grow their businesses. That’s why we are pleased to recognize Richard as one of the most intriguing entrepreneurs of 2020.”
In addition to honoring 100 entrepreneurs, the summit, which this year will take place virtually, consists of general sessions and clinics led by seasoned entrepreneurs, academics and business leaders as well as resident scholars.

About ReadCoor
ReadCoor is a technology company offering the first true spatial multi-omic platform to the global audience of researchers, clinicians, pharma and diagnostics companies to expand understanding of human biology and to facilitate the creation of new therapeutics for patients. The company’s RC2 Platform simultaneously detects and reads the sequences of tens to thousands of RNA, DNA, proteins, and therapeutics and visualizes sub-cellular nanoscale 3D resolution in every cell throughout any tissue section. The Platform, based on ReadCoor’s proprietary Fluorescent in situ Sequencing (FISSEQ) technology, combines the massive multiplexity of next-generation sequencing (NGS) and high-resolution tissue imaging.

Media Contact
Jermaine Reid
ReadCoor
617-453-2660
jermaine.reid@readcoor.com